Team 4 – STAFF – Members

NEWS

You are here: Home > Factors of persistence of leukemic cells > STAFF - MEMBERS

FACTORS OF PERSISTENCE OF LEUKEMIC CELLS TEAM

MEMBERS

Katarina-Jovanovic

Dr JOVANOVIC Katarina, PhD
Post-doctoral researcher

Elisabeth-Bertrand

BERTRAND Elisabeth
Technician- Lille University Hospital
In charge of L2 Laboratories (IRCL).

Adeline-Barthelemy

Dr BARTHELEMY Adeline, PhD
Research Engineer

Romain-Magnez

MAGNEZ Romain
Engineer

William-Laine

LAINE William
Technician University of Lille

Alexia-Mopin

MOPIN Alexia
PhD Student
Thesis topic: Role of regulatory and WT1-specific T lymphocyte responses in a mouse model of minimal residual leukemia.
PhD Thesis Supervisor: Carine Brinster.

Samy-Jambon

JAMBON Samy, PharmD
PhD Student
Thesis topic: Role of HOXA9 and effect of inhibitor compounds in several solid tumors .
PhD Thesis Supervisor: Marie-Hélène David.

Committee member for scientific meetings organization (JPARC center).

Julie-Berthe

BERTHE Julie
PhD Student
Thesis topic:
Role of PD-L1 on breast cancer cells.
PhD Thesis Supervisors: Bruno Quesnel/ Sylvie Galiègue-Zouitina.

Fanny-Gonzales

GONZALES Fanny, MD
PhD Student
Thesis topic: Functions of CD81 in leukemogenesis and on prognosis in pediatric acute myeloid leukemia.
PhD Thesis Supervisor: Meyling Cheok.

Anne-Trinh

TRINH Anne
PhD Student
Thesis topic:
Mitochondrial metabolism targeting of dormant leukemic cells.
PhD Thesis Supervisor: Philippe Marchetti.

Raeeka-Khamari

KHAMARI Raeeka
PhD Student
Thesis topic: Mitochondrial targeting of persitant cells in acute myeloid leukemia after exposure of targeted therapies.
PhD Thesis Supervisor: Jérôme Kluza.

lea

FLECHON Lea

PhD Student

PhD Thesis Supervisors: Thierry Idziorek et Salomon Manier

index

MITRA Suman, PhD
Researcher (CPER Cancer)

Research project: Common gamma-chain (gc) family of cytokines, including IL-2, IL-15, IL-21 are critical regulator of T cell activity but their actions are often pleiotropic, which possess a major challenge for their use to treat diseases, including cancer.  Our research focuses on understanding molecular mechanisms by which these cytokines mediate their pleiotropic actions to identify strategies to utilize power of cytokines to modulate T cell responses in cancer. In particular, we are studing how cytokine signaling pathways can be fine-tuned to refine current immunotherapy drugs, including checkpoint blockade, CAR-T therapy as well as use cancer vaccine therapy.  

Foto - Silvia Gaggero

GAGGERO Silvia, PhD
Post-doctoral Researcher.

CPER Cancer- Suman MITRA’s group.

images

COZZANI Adeline
Engineer

CPER Cancer. Suman MITRA’s group